CN111514052A - Soft and skin-tendering two-phase sleep mask and preparation method thereof - Google Patents
Soft and skin-tendering two-phase sleep mask and preparation method thereof Download PDFInfo
- Publication number
- CN111514052A CN111514052A CN202010526486.8A CN202010526486A CN111514052A CN 111514052 A CN111514052 A CN 111514052A CN 202010526486 A CN202010526486 A CN 202010526486A CN 111514052 A CN111514052 A CN 111514052A
- Authority
- CN
- China
- Prior art keywords
- phase
- sleep mask
- skin
- percent
- propylene glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 239000012071 phase Substances 0.000 claims abstract description 151
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 44
- 239000004475 Arginine Substances 0.000 claims abstract description 25
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000008384 inner phase Substances 0.000 claims abstract description 25
- 239000000284 extract Substances 0.000 claims abstract description 24
- SCVVSSZVLZQUDZ-UHFFFAOYSA-N 3-methyl-2,6-dihydro-1H-pyrimidine-2-carboxylic acid Chemical compound CN1C(NCC=C1)C(=O)O SCVVSSZVLZQUDZ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000004902 Softening Agent Substances 0.000 claims abstract description 18
- 244000025352 Artocarpus heterophyllus Species 0.000 claims abstract description 17
- 235000008725 Artocarpus heterophyllus Nutrition 0.000 claims abstract description 17
- 239000008385 outer phase Substances 0.000 claims abstract description 16
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 15
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 15
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 15
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 15
- 239000001168 astaxanthin Substances 0.000 claims abstract description 15
- 229920005862 polyol Polymers 0.000 claims abstract description 15
- 150000003077 polyols Chemical class 0.000 claims abstract description 15
- 239000003755 preservative agent Substances 0.000 claims abstract description 12
- 230000002335 preservative effect Effects 0.000 claims abstract description 12
- 239000002562 thickening agent Substances 0.000 claims abstract description 11
- 239000000725 suspension Substances 0.000 claims abstract description 9
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 7
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 6
- 150000002191 fatty alcohols Chemical class 0.000 claims abstract description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 110
- 235000011187 glycerol Nutrition 0.000 claims description 41
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 41
- 239000000203 mixture Substances 0.000 claims description 41
- -1 alkyl glucoside Chemical class 0.000 claims description 34
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 claims description 30
- 239000000049 pigment Substances 0.000 claims description 30
- 239000000230 xanthan gum Substances 0.000 claims description 30
- 229920001285 xanthan gum Polymers 0.000 claims description 30
- 229940082509 xanthan gum Drugs 0.000 claims description 30
- 235000010493 xanthan gum Nutrition 0.000 claims description 30
- 230000001804 emulsifying effect Effects 0.000 claims description 28
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 238000010438 heat treatment Methods 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 17
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 16
- 229920002125 Sokalan® Polymers 0.000 claims description 16
- 229960001631 carbomer Drugs 0.000 claims description 16
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 16
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 16
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 15
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 15
- 229920001577 copolymer Polymers 0.000 claims description 15
- 229930182478 glucoside Natural products 0.000 claims description 15
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 15
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 14
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 12
- 229960003966 nicotinamide Drugs 0.000 claims description 10
- 235000005152 nicotinamide Nutrition 0.000 claims description 10
- 239000011570 nicotinamide Substances 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 9
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 8
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 8
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 8
- 229940075529 glyceryl stearate Drugs 0.000 claims description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 8
- 229940100460 peg-100 stearate Drugs 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 239000011265 semifinished product Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 239000005711 Benzoic acid Substances 0.000 claims description 6
- 235000010233 benzoic acid Nutrition 0.000 claims description 6
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 6
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 claims description 5
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 claims description 5
- 239000005022 packaging material Substances 0.000 claims description 5
- 229940104261 taurate Drugs 0.000 claims description 5
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 5
- 239000004381 Choline salt Substances 0.000 claims description 4
- 235000019417 choline salt Nutrition 0.000 claims description 4
- 239000003974 emollient agent Substances 0.000 claims description 4
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 150000003248 quinolines Chemical class 0.000 claims description 3
- 229920005573 silicon-containing polymer Polymers 0.000 claims description 3
- 230000002051 biphasic effect Effects 0.000 claims 9
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims 4
- 229940008099 dimethicone Drugs 0.000 claims 3
- 241000158723 Melia Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 230000037303 wrinkles Effects 0.000 abstract description 5
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract description 4
- 238000005282 brightening Methods 0.000 abstract description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract 1
- 229960001231 choline Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 39
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 21
- 235000009697 arginine Nutrition 0.000 description 19
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 18
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 15
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 15
- 229960002216 methylparaben Drugs 0.000 description 15
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 10
- 229960005323 phenoxyethanol Drugs 0.000 description 10
- 229940051250 hexylene glycol Drugs 0.000 description 9
- GHBFNMLVSPCDGN-UHFFFAOYSA-N caprylic acid monoglyceride Natural products CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 230000003020 moisturizing effect Effects 0.000 description 8
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 description 7
- 229940087068 glyceryl caprylate Drugs 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 6
- 102000002322 Egg Proteins Human genes 0.000 description 5
- 108010000912 Egg Proteins Proteins 0.000 description 5
- 206010040954 Skin wrinkling Diseases 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 210000002969 egg yolk Anatomy 0.000 description 5
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 5
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 4
- 241001098027 Callerya speciosa Species 0.000 description 4
- 235000005979 Citrus limon Nutrition 0.000 description 4
- 244000131522 Citrus pyriformis Species 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 235000013736 caramel Nutrition 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 235000014103 egg white Nutrition 0.000 description 4
- 210000000969 egg white Anatomy 0.000 description 4
- 239000004519 grease Substances 0.000 description 4
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 3
- 229940100573 methylpropanediol Drugs 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 239000000940 FEMA 2235 Substances 0.000 description 2
- 235000007328 Hericium erinaceus Nutrition 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- 230000001839 systemic circulation Effects 0.000 description 2
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 2
- YPUZOECTETYPRF-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrimidine-2-carboxylic acid Chemical compound OC(=O)C1NCC=CN1 YPUZOECTETYPRF-UHFFFAOYSA-N 0.000 description 1
- AQTKXCPRNZDOJU-ZEBDFXRSSA-N 2-O-(alpha-D-glucopyranosyl)glycerol Chemical compound OCC(CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AQTKXCPRNZDOJU-ZEBDFXRSSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 241000378467 Melaleuca Species 0.000 description 1
- 235000000434 Melocanna baccifera Nutrition 0.000 description 1
- 241001497770 Melocanna baccifera Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000002508 compound effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000036619 pore blockages Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a soft and tender two-phase sleep mask and a preparation method thereof, wherein the two-phase sleep mask consists of an inner phase at the central position and an outer phase at the periphery, and the inner phase comprises: emulsifier: 2 to 4 percent; oily component: 5 to 12 percent; fatty alcohol: 0.5-2%; first suspension thickener: 0.5-1%; first skin softening agent: 0.5-5%, the first skin softening agent comprises one or more of tetrahydro-methyl pyrimidine carboxylic acid, astaxanthin, and extract of leaves/stems of Artocarpus heterophyllus; first polyol: 5 to 10 percent; a soothing agent: 0.05 to 0.2 percent; a first preservative; the external phase comprises: second suspension thickener: 0.3 to 1.8 percent; a second skin softening agent: 0.5-4%, and the second skin softening agent comprises one or more of nicotinamide, extract of leaves/stems of Artocarpus heterophyllus, and choline glycerophosphoinositide salt; a second polyol: 3 to 10 percent; arginine: 0.2-0.8% of second preservative. The two-phase sleep mask has excellent water replenishing capacity, can quickly improve the moisture content of the horny layer of the skin, and has excellent effects of softening the skin, removing wrinkles and brightening the skin. The appearance shape is similar to egg, and the utility model is attractive.
Description
Technical Field
The invention relates to the field of cosmetics, in particular to a soft and skin-tendering two-phase sleep mask and a preparation method thereof.
Background
The sleep mask is generally single-phase gel or cream, is used before sleep, and prevents the contact of facial skin and air through a layer of essence dressing, so as to prevent the evaporation of skin water%, increase the moisture retention of stratum corneum and soften cutin; meanwhile, blood circulation is accelerated after the temperature of the skin rises, and the absorption of the skin on nutrient components in the sleep mask is increased, so that the epidermis layer of the skin is full and smooth, and the skin is smooth, fine, fair and bright.
The traditional sleeping mask is divided into a washing-free type and a washing-off type, wherein the washing-free type sleeping mask is generally used before sleeping and washed off in the morning next day, and the washing-free type sleeping mask mainly comprises water, a humectant, a thickening agent, an emulsifier, grease and a preservative, and is usually in a semi-transparent gel or cream shape; the moisture content is usually 80-90%, the main components of the sleep mask which play a role in softening, moisturizing and sealing the skin are grease, and when the grease is excessively added, acne and pore blockage are easily caused after the sleep mask is applied for one night; when the amount of the added oil is too low, the ideal softening and skin-tendering effects cannot be achieved.
Meanwhile, because the traditional sleeping mask is limited in dosage form, grease, an emollient and functional components beneficial to the skin cannot be added in a large amount, and the balance between usability and functionality cannot be achieved, so that the effects in the aspects of skin moistening, softening, skin tendering and the like cannot be maximized.
Disclosure of Invention
The technical problem to be solved by the invention is to provide a soft and skin-tendering two-phase sleep mask, which can automatically adjust the freshness of the sleep mask and ensure the maximization of functions.
As a first aspect of the present invention, the technical solution adopted by the present invention to solve the technical problem is: provides a soft and tender skin two-phase sleep mask which consists of an inner phase at the central position and an outer phase at the periphery, and comprises the following components in percentage by mass,
the internal phase comprises the components:
emulsifier: 2 to 4 percent;
oily component: 5 to 12 percent;
fatty alcohol: 0.5-2%, wherein the fatty alcohol comprises C14-22 alcohol and cetyl stearate alcohol;
first suspension thickener: 0.5-1%;
first skin softening agent: 0.5-5%, the first emollient of the inner phase comprises one or more of a tetrahydro-methyl pyrimidine carboxylic acid, astaxanthin, extract of leaves/stems of Artocarpus heterophyllus;
first polyol: 5 to 10 percent;
a soothing agent: 0.05 to 0.2 percent;
a first preservative: 0.1 to 1 percent;
water, the balance;
the external phase comprises the following components:
second suspension thickener: 0.3 to 1.8 percent;
a second skin softening agent: 0.5-4%, wherein the skin softening agent of the external phase comprises one or more of niacinamide, extract of leaves/stems of Artocarpus heterophyllus, and choline salt of glycerophosphoinositide;
a second polyol: 3 to 10 percent;
a second preservative: 0.1 to 1 percent;
arginine: 0.2 to 0.8 percent;
water: and (4) the balance.
Preferably, the first skin softening agent comprises 0.5% of tetrahydro-methyl pyrimidine carboxylic acid, 0.05% of astaxanthin and 0.5% of the extract of leaves/stems of Artocarpus heterophyllus.
In the invention, the inner phase adopts the tetrahydro-methyl pyrimidine carboxylic acid and the extract of the leaves/stems of the millettia speciosa, and is matched with the astaxanthin, so that the moisturizing cream has excellent moisturizing capability, can quickly improve the moisture content of the horny layer of the skin, and has very excellent effects of softening the skin, removing wrinkles and brightening the skin. For the external phase, the glycerol phosphoinositide choline salt and the extract of the leaves/stems of the millettia speciosa are adopted and matched with the nicotinamide, the efficacy of the skin softening agent substance can be well absorbed through the surface layer of the skin and enter the deep layer and the systemic circulation, and the components have synergistic effect, so that the skin softening agent has very excellent repairing, moisturizing, antioxidant and anti-aging effects, and is smooth, soft, tender and clear.
Preferably, the first suspension thickener of the inner phase comprises xanthan gum, ammonium acryloyldimethyltaurate/VP copolymer.
Preferably, the second suspension thickening agent of the outer phase comprises carbomer, xanthan gum and sodium hyaluronate, and the carbomer accounts for 0.1-0.8% by mass; xanthan gum is 0.1-0.5%; the content of sodium hyaluronate is 0.1-0.5%.
Preferably, the emulsifier of the inner phase is a C14-22 alcohol/C12-20 alkyl glucoside, glyceryl stearate, PEG-100 stearate. Preferably, the fatty alcohol is cetearyl alcohol.
Preferably, the first polyol and the second polyol are both one or two of glycerol and methyl propylene glycol.
Preferably, the first and second polyols are a combination of glycerol and methyl propylene glycol, the mass ratio of glycerol to methyl propylene glycol of the first polyol in the inner phase being 2: 3; the second polyol in the outer phase had a ratio of glycerol to methyl propylene glycol of 3:5 by mass.
Preferably, the oily component of the internal phase is one or more of cyclopentadimethylsiloxane/cyclohexasiloxane, polydimethylsiloxane.
Preferably, the oily component is a composition of cyclopentadimethicone/cyclohexasiloxane and polydimethylsiloxane, and the mass ratio of the cyclopentadimethicone/cyclohexasiloxane to the polydimethylsiloxane is 6: 2.
Preferably, the soothing agents of the internal phase are: butanediol/1, 2-pentanediol/hydroxyphenylpropionamide benzoic acid/water compositions.
Preferably, the inner phase also comprises a first pigment and essence, and the first pigment is 0.1-0.5% by mass; the essence is 0.05-0.2%.
Preferably, the external phase further comprises a pigment, and the external phase further comprises a second pigment in percentage by mass, wherein the second pigment is 0.1-0.5% in percentage by mass.
In the invention, the first pigment of the inner phase is a mixed composition of I.O.Y AS and I.O.R AS, wherein the mass ratio of the I.O.Y AS to the I.O.R AS is 5: 3; the second coloring matter of the outer phase is a mixture of caramel coloring matter (caramel color) and lemon yellow (CI 19140). Wherein the mass ratio of the caramel pigment to the lemon yellow is 7.4: 1.
As a second aspect of the present invention, the present invention also provides a method for preparing the above two-phase sleep mask, comprising:
step 1: preparation of an internal phase composition, wherein the preparation of the internal phase composition comprises the steps of:
weighing the components according to the mass percentage, taking C14-22 alcohol/C12-20 alkyl glucoside, glyceryl stearate, PEG-100 stearate, cetearyl alcohol, cyclopenta dimethyl silicone polymer/cyclohexasiloxane and dimethyl silicone polymer as phase A raw materials, placing the phase A raw materials in an oil phase pot, heating to 80-85 ℃, and uniformly mixing to form phase A;
putting glycerol, methyl propylene glycol, methyl hydroxybenzoate, xanthan gum, acryloyl dimethyl ammonium taurate/VP copolymer and water as raw materials of phase B in a water phase pot, heating to 80-85 deg.C, and mixing to form phase B;
adding the phase B into an emulsifying pot, adding the phase A into the emulsifying pot containing the phase B, controlling the stirring speed in the emulsifying pot to be 30-45rpm, starting homogenizing for 5-7 minutes, controlling the homogenizing speed to be 2000-3000rpm, preserving heat for 25-30 minutes, and vacuumizing for defoaming;
cooling the emulsifying pot, adding a first preservative, a first pigment, essence, a first skin softening agent and a soothing agent when the emulsifying pot is cooled to 35-40 ℃, uniformly stirring, and then vacuumizing again for defoaming to obtain an inner phase composition;
step 2: preparation of an external phase composition, wherein the preparation of the external phase composition comprises the steps of:
weighing the components according to the mass percentage, putting water, carbomer, glycerol, methyl propylene glycol, sodium hyaluronate, xanthan gum and methyl hydroxybenzoate into an emulsifying pot, heating to 80-85 ℃, uniformly mixing to form a phase C, carrying out vacuum defoaming on the phase C, and then cooling;
preheating arginine and water in a ratio of 1:5 to dissolve into an arginine aqueous solution, stirring and cooling the arginine aqueous solution to 60-65 ℃ in an emulsifying pot, adding the arginine aqueous solution into the phase C, and uniformly mixing;
and cooling the emulsifying pot, adding a second preservative, a second pigment and a second skin softening agent when the emulsifying pot is cooled to 35-40 ℃, uniformly stirring, and then vacuumizing and defoaming again to obtain the external-phase composition.
Further, as a third aspect of the present invention, the present invention further provides a method for preparing a two-phase sleep mask, comprising the steps of:
step A, filling an external phase composition, namely adding the prepared external phase composition into a filling machine with a heating device, stirring and heating to 55-60 ℃, adjusting the filling machine to fill 55% of the external phase composition into a packaging material to obtain a semi-finished product;
in this step, the outer phase is heated to 55 to 60 ℃ for the purpose of enhancing the fluidity of the outer phase so that the inner phase is poured thereinto in the subsequent step;
and step B, filling the internal phase composition, adding the prepared internal phase composition into a filling machine, adjusting the filling opening of the filling machine to enable the filling opening to be opposite to the center of the semi-finished product prepared in the step 1, and filling the internal phase composition with the volume of 45% of the packaging material into the semi-finished product to obtain a finished product of the two-phase sleep mask.
The final shape of the two-phase sleep mask finished product prepared by the invention is that the outer phase wraps the inner phase in a half-wrapping mode, the inner phase is circular when viewed from the section of the product, and the outer phase is a concentric ring wrapping the inner phase. The whole product is shaped into a novel egg appearance shape, the inner phase is in a yolk cream state, the outer phase is in an egg white gel state, the inner phase is similar to yolk, and the outer phase is similar to egg white wrapping the yolk, so that the attraction of consumers is enhanced. When the two-phase sleep mask finished product is used, the internal phase and the external phase are uniformly mixed firstly and then used.
Compared with the prior art, the two-phase sleep mask has the beneficial effects that the tetrahydro-methyl pyrimidine carboxylic acid and the extract of the leaves/stems of the millettia speciosa are selected, and the astaxanthin is matched as the first skin softening agent, so that the two-phase sleep mask has excellent water replenishing capacity, can quickly improve the moisture content of the horny layer of the skin, and has very excellent effects of softening the skin, removing wrinkles and brightening the skin. The preparation method selects the glycerophosphoinositide choline salt and the extract of the leaves/stems of the Artocarpus heterophyllus in combination with the nicotinamide, has the advantages that the function is well absorbed through the surface layer of the skin and enters the deep layer and the systemic circulation, and all the components have the synergistic effect, so the preparation method has excellent repairing, moisturizing, antioxidant and anti-aging effects, and makes the skin smooth, soft, tender and clear. Meanwhile, the two-phase sleep mask has the advantages that the inner phase is in an egg yolk cream state, the outer phase is in an egg white gel state, the appearance shape is exactly like eggs, and the two-phase sleep mask has attractive force.
Detailed Description
The technical solutions of the present invention are further illustrated by the following specific examples, which do not represent limitations to the scope of the present invention. Insubstantial modifications and adaptations of the present invention by others of the concepts fall within the scope of the invention.
The invention provides a novel two-phase sleep mask which has a two-phase double-material-body structure of 'inner yolk + outer egg white', and can moisten skin, shrink pores and tighten skin, so that the skin is soft, tender and elastic.
The C14-22 alcohol/C12-20 alkyl glucoside adopted by the embodiment of the invention has the mixture ratio of 68:32, is from French Saibox and has the trade name of MONTANOV L;
the glyceryl stearate/PEG-100 stearate adopted in the embodiment of the invention is from British Poa and has a trade name of A170;
the cetearyl alcohol adopted in the embodiment of the invention is from German Kening and has a trade name of Lanete O;
the cyclopentasiloxane/cyclohexasiloxane used in the examples of the present invention was obtained from Dow chemical, USA under the trade name DC 345;
the polydimethylsiloxane adopted in the embodiment of the invention is from Dow Corning, USA, and has a trade name of PMX-200Fluid/100 cst;
the i.o.y AS used in the embodiments of the present invention is from the korean ENTOP, and has a trade name of i.o.y AS;
the i.o.ras used in the examples of the present invention is from the korean ENTOP under the trade name i.o.r AS;
the caramel pigment (caramel color) adopted by the embodiment of the invention is from a lion head pigment and is sold under the trade name of caramel pigment;
the lemon yellow (CI 19140) adopted by the embodiment of the invention is prepared from lion head pigment with the trade name of lemon yellow;
the Glycerin adopted in the embodiment of the invention is from Muli, Malaysia, and has a trade name of Glycerin;
the methylpropanediol used in the examples of the present invention was obtained from CM of Korea under the trade name CM-PG;
the methyl hydroxybenzoate adopted by the embodiment of the invention is from Chinese Shengxiao, and the trade name is Methylparaben;
the xanthan gum adopted by the embodiment of the invention is from Spanish Keke in America and has a trade name of DELTROL CG-T;
the acryloyl dimethyl ammonium taurate/VP copolymer adopted by the embodiment of the invention is from Kelaien and has the trade name of AVC;
the phenoxyethanol/ethylhexyl glycerin adopted in the embodiment of the invention is from German Shumei and has a trade name of PE 9010;
the glycerol caprylate/caprylhydroxamic acid/propylene glycol adopted in the embodiment of the invention is from Korean CM, has a trade name of A91, is a raw material which is sold in Korean CM in a fixed ratio of 20:10: 70;
the butanediol/1, 2-pentanediol/hydroxyphenylpropionamide benzoic acid/water adopted by the embodiment of the invention is from Senxin in the United states, the trade name of the butanediol/1, 2-pentanediol/hydroxyphenylpropionamide benzoic acid/water is SymClamin, and the butanediol/1, 2-pentanediol/hydroxyphenylpropionamide benzoic acid/water is sold in Senxin, wherein the ratio of the butanediol/1, 2-pentanediol/hydroxyphenylpropionamide benzoic acid/water is 87:5:3: 5;
the tetrahydro-methyl pyrimidine carboxylic acid adopted in the embodiment of the invention is from Japan and has the trade name of Ectoin;
the extract of leaves/stems of Artocarpus heterophyllus adopted in the embodiment of the invention is from BITOP of Germany, and has the trade name GLYCOIN;
the astaxanthin adopted in the embodiment of the invention is from the United states and is sold under the trade name of BIO-ATS O5;
the nicotinamide used in the examples of the present invention was obtained from CM of Korea under the trade name VB 3;
carbomer adopted in the embodiment of the invention is from Japan and has the trade name HP-505C;
the sodium hyaluronate adopted by the embodiment of the invention is from Chinese Furuida, and HAs a trade name of HA;
arginine used in the examples of the present invention was obtained from CM of Korea under the trade name L-Arginine;
the Hexanediol used in the examples of the present invention was obtained from CM of Korea under the trade name Hexanediol;
the filling machine in the embodiment of the invention adopts an QGJ pneumatic filling machine produced by Jiushan light industrial plant in Wenzhou city;
the filling machine with the heating device in the embodiment of the invention adopts a TVFA 1-10 full-pneumatic semi-automatic piston type filling machine produced by Guangzhou city combined automatic mechanical science and technology Limited.
Example 1:
a soft and skin-tendering two-phase sleep mask comprises the following formula:
the internal phase comprises the following components in percentage by weight: 3% of C14-22 alcohol/C12-20 alkyl glucoside, 2% of cetylstearyl alcohol, 9% of cyclopentasiloxane/cyclohexasiloxane, 0.02% of astaxanthin, 4% of polydimethylsiloxane, 3% of glycerol, 5% of methyl propylene glycol, 0.15% of methylparaben, 0.2% of xanthan gum, 0.8% of acryloyldimethyl taurate/VP copolymer, 0.6% of phenoxyethanol/ethylhexyl glycerol, 0.1% of tetrahydromethylpyrimidine carboxylic acid, 0.2% of extract of leaves/stems of Artocarpus heterophyllus, 0.1% of essence and the balance of water;
the external phase comprises the following components in percentage by weight: carbomer 0.6%, glycerin 5%, methyl propylene glycol 5%, xanthan gum 0.2%, methylparaben 0.15%, arginine 0.6%, hexylene glycol 0.5%, nicotinamide 0.2%, tetrahydro-methyl pyrimidine carboxylic acid 0.2%, Artocarpus heterophyllus leaf/stem extract 0.2%, pigment 0.02%, and water in balance.
The two-phase cosmetic of this example was prepared according to the following preparation method, which comprises the steps of:
preparation of internal phase composition
(1) Weighing the components according to the formula, taking C14-22 alcohol/C12-20 alkyl glucoside, cetearyl alcohol, astaxanthin, cyclopenta dimethyl siloxane/cyclohexasiloxane and polydimethylsiloxane as phase A raw materials, placing the phase A raw materials in an oil phase pot, heating to 80-85 ℃, and uniformly mixing to form phase A;
(2) putting glycerol, methyl propylene glycol, methyl hydroxybenzoate, xanthan gum, 0.8% of acryloyl dimethyl taurate/VP copolymer and water in a water phase pot, heating to 80-85 deg.C, and mixing to form phase B;
(3) respectively heating the phase A and the phase B to 80-85 ℃, starting stirring, controlling the stirring speed at 15-20rpm, and continuing to preserve heat for 20 minutes after the phase A and the phase B are completely dissolved respectively;
(4) pumping the phase B into an emulsifying pot, adding the phase A into the emulsifying pot containing the phase B, controlling the stirring speed in the emulsifying pot at 30-45rpm, starting homogenizing for 5 minutes, controlling the homogenizing speed at 3000rpm of 2000-plus materials, preserving heat for 25-30 minutes, and vacuumizing for defoaming;
(5) cooling the emulsifying pot, adding the first preservative, the first pigment, the essence, the tetrahydromethylpyrimidine carboxylic acid and the millettia speciosa leaf/stem extract when the emulsifying pot is stirred and cooled to 35-40 ℃, uniformly stirring, and vacuumizing again for deaeration to obtain the inner phase composition.
Preparation of two-phase and external-phase composition
(6) Weighing the components according to the formula, mixing carbomer, glycerol, methyl propylene glycol and xanthane
Adding glue, methyl hydroxybenzoate and water into an emulsifying pot, starting stirring at 30-45rpm, heating to 80-85 deg.C, maintaining the temperature for 20-30 min, mixing to form phase C, vacuum defoaming the phase C, and cooling;
(7) preheating arginine and water in a ratio of 1:5 to dissolve into an arginine aqueous solution, stirring and cooling the arginine aqueous solution to 60-65 ℃ in an emulsifying pot, controlling the speed at 30-45rpm, adding the arginine aqueous solution into the phase C, and uniformly mixing;
(8) cooling the emulsifying pot, adding second antiseptic, second pigment, nicotinamide, tetrahydro-methyl pyrimidine carboxylic acid, and folium Meliloti extract into the emulsifying pot when the emulsifying pot is cooled to 35-40 deg.C, mixing, and vacuum defoaming to obtain the external phase composition.
Product filling process
Step A, filling an external phase mixture, adding the prepared external phase composition into a filling machine with a heating device, stirring and heating to 55-60 ℃, adjusting the filling machine to fill 55% of the external phase composition into a packaging material to obtain a semi-finished product;
and step B, filling the internal phase composition, adding the prepared internal phase composition into a filling machine, adjusting the filling opening of the filling machine to enable the filling opening to be opposite to the center of the semi-finished product prepared in the step A, and adjusting the filling machine to fill the internal phase composition with 45% of the volume of the packing material to obtain a finished product of the two-phase sleep mask.
Example 2:
a soft and skin-tendering two-phase sleep mask comprises the following formula:
the internal phase comprises the following components in percentage by weight: 3% of C14-22 alcohol/C12-20 alkyl glucoside, 2% of cetylstearyl alcohol, 9% of cyclopentasiloxane/cyclohexasiloxane, 4% of polydimethylsiloxane, 3% of glycerol, 5% of methyl propylene glycol, 0.15% of methylparaben, 0.2% of xanthan gum, 0.8% of acryloyldimethyl taurate/VP copolymer, 0.6% of phenoxyethanol/ethylhexyl glycerol, 0.2% of tetrahydromethylpyrimidine carboxylic acid, 0.2% of Artocarpus heterophyllus leaf/stem extract, 0.1% of essence and the balance of water;
the external phase comprises the following components in percentage by weight: carbomer 0.6%, glycerin 5%, methyl propylene glycol 5%, xanthan gum 0.2%, sodium hyaluronate 0.1%, methylparaben 0.15%, arginine 0.6%, hexylene glycol 0.5%, tetrahydro-methyl pyrimidine carboxylic acid 0.2%, Artocarpus heterophyllus leaf/stem extract 0.2%, pigment 0.02%, and water in balance.
The preparation process is the same as in example 1.
Example 3:
a soft and skin-tendering two-phase sleep mask comprises the following formula:
the internal phase comprises the following components in percentage by weight: 2% of C14-22 alcohol/C12-20 alkyl glucoside, 1% of glyceryl stearate/PEG-100 stearate, 0.02% of astaxanthin, 2% of cetyl stearate alcohol, 4% of cyclopentadimethylsiloxane/cyclohexasiloxane, 2% of polydimethylsiloxane, 3% of glycerol, 5% of methyl propylene glycol, 0.15% of methylparaben, 0.2% of xanthan gum, 0.8% of ammonium acryloyldimethyltaurate/VP copolymer, 0.15% of phenoxyethanol/ethylhexylglycerol, 0.5% of glyceryl caprylate/caprylhydroxamic acid/propylene glycol, 0.3% of tetrahydropyrimidine carboxylic acid, 0.1% of perfume, the balance water;
the external phase comprises the following components in percentage by weight: carbomer 0.6%, glycerin 5%, methyl propylene glycol 5%, xanthan gum 0.2%, sodium hyaluronate 0.1%, methylparaben 0.15%, arginine 0.6%, hexylene glycol 0.5%, glyceryl caprylate/caprylhydroxamic acid/propylene glycol 0.5%, niacinamide 0.5%, tetrahydromethyl pyrimidinecarboxylic acid 0.3%, Artocarpus heterophyllus leaf/stem extract 0.3%, pigment 0.02%, and water in balance.
The preparation process is the same as in example 1.
Example 4:
a soft and skin-tendering two-phase sleep mask comprises the following formula:
the internal phase comprises the following components in percentage by weight: 2% of C14-22 alcohol/C12-20 alkyl glucoside, 1% of glyceryl stearate/PEG-100 stearate, 2% of cetearyl alcohol, 4% of cyclopentadimethylsiloxane/cyclohexasiloxane, 2% of polydimethylsiloxane, 3% of glycerol, 5% of methylpropanediol, 0.15% of methylparaben, 0.2% of xanthan gum, 0.8% of ammonium acryloyldimethyltaurate/VP copolymer, 0.15% of phenoxyethanol/ethylhexylglycerol, 0.5% of glyceryl caprylate/caprylhydroxamic acid/propylene glycol, 0.4% of tetrahydromethylpyrimidine carboxylic acid, 0.1% of perfume, balance of water;
the external phase comprises the following components in percentage by weight: carbomer 0.6%, glycerin 5%, methyl propylene glycol 5%, xanthan gum 0.2%, sodium hyaluronate 0.1%, methylparaben 0.15%, arginine 0.6%, hexylene glycol 0.5%, glyceryl caprylate/caprylhydroxamic acid/propylene glycol 0.5%, niacinamide 0.4%, tetrahydromethyl pyrimidinecarboxylic acid 0.4%, Artocarpus heterophyllus leaf/stem extract 0.4%, pigment 0.02%, and water in balance.
The preparation process is the same as in example 1.
Example 5:
a soft and skin-tendering two-phase sleep mask comprises the following formula:
the internal phase comprises the following components in percentage by weight: 2% of C14-22 alcohol/C12-20 alkyl glucoside, 1% of glyceryl stearate/PEG-100 stearate, 1.5% of cetearyl alcohol, 6% of cyclopentadimethylsiloxane/cyclohexasiloxane, 0.05% of astaxanthin, 2% of polydimethylsiloxane, 2% of glycerol, 3% of methylpropanediol, 0.15% of methylparaben, 0.1% of xanthan gum, 0.75% of ammonium acryloyldimethyltaurate/VP copolymer, 0.15% of phenoxyethanol/ethylhexylglycerol, 0.5% of glyceryl caprylate/caprylhydroxamic acid/propylene glycol, 0.5% of tetrahydromethylpyrimidine carboxylic acid, 0.5% of melaleuca leaf/stem extract, 0.1% of perfume, the balance water;
the external phase comprises the following components in percentage by weight: carbomer 0.6%, glycerin 3%, methyl propylene glycol 5%, xanthan gum 0.12%, sodium hyaluronate 0.02%, methylparaben 0.1%, arginine 0.6%, hexylene glycol 0.3%, glyceryl caprylate/caprylhydroxamic acid/propylene glycol 0.5%, niacinamide 0.5%, tetrahydromethyl pyrimidinecarboxylic acid 0.5%, Artocarpus heterophyllus leaf/stem extract 0.5%, pigment 0.02%, and water in balance.
The preparation process is the same as in example 1.
Comparative example 1:
a soft and skin-tendering two-phase sleep mask comprises the following formula:
the internal phase comprises the following components in percentage by weight: 3% of C14-22 alcohol/C12-20 alkyl glucoside, 2% of cetylstearyl alcohol, 9% of cyclopentasiloxane/cyclohexasiloxane, 4% of polydimethylsiloxane, 3% of glycerol, 5% of methyl propylene glycol, 0.15% of methyl hydroxybenzoate, 0.2% of xanthan gum, 0.8% of acryloyldimethyl ammonium taurate/VP copolymer, 0.6% of phenoxyethanol/ethylhexyl glycerol, 0.1% of essence and the balance of water;
the external phase comprises the following components in percentage by weight: carbomer 0.6%, glycerin 5%, methyl propylene glycol 5%, xanthan gum 0.2%, sodium hyaluronate 0.1%, methylparaben 0.15%, arginine 0.6%, hexylene glycol 0.5%, pigment 0.02%, and the balance of water.
The preparation process is the same as in example 1.
Comparative example 2:
a soft and skin-tendering two-phase sleep mask comprises the following formula:
the internal phase comprises the following components in percentage by weight: 3% of C14-22 alcohol/C12-20 alkyl glucoside, 2% of cetylstearyl alcohol, 0.02% of astaxanthin, 9% of cyclopenta dimethyl siloxane/cyclohexasiloxane, 4% of dimethyl siloxane, 3% of glycerol, 5% of methyl propylene glycol, 0.15% of methyl hydroxybenzoate, 0.2% of xanthan gum, 0.8% of acryloyl dimethyl taurate/VP copolymer, 0.6% of phenoxyethanol/ethylhexyl glycerol, 0.1% of essence and the balance of water;
the external phase comprises the following components in percentage by weight: carbomer 0.6%, glycerin 5%, methyl propylene glycol 5%, xanthan gum 0.2%, sodium hyaluronate 0.1%, methylparaben 0.15%, arginine 0.6%, hexylene glycol 0.5%, pigment 0.02%, and the balance of water.
The preparation process is the same as in example 1.
Comparative example 3:
a soft and skin-tendering two-phase sleep mask comprises the following formula:
the internal phase comprises the following components in percentage by weight: 3% of C14-22 alcohol/C12-20 alkyl glucoside, 2% of cetylstearyl alcohol, 9% of cyclopentasiloxane/cyclohexasiloxane, 4% of polydimethylsiloxane, 3% of glycerol, 5% of methyl propylene glycol, 0.15% of methyl hydroxybenzoate, 0.2% of xanthan gum, 0.8% of acryloyldimethyl ammonium taurate/VP copolymer, 0.6% of phenoxyethanol/ethylhexyl glycerol, 0.1% of essence and the balance of water;
the external phase comprises the following components in percentage by weight: carbomer 0.6%, glycerin 5%, methyl propylene glycol 5%, xanthan gum 0.2%, sodium hyaluronate 0.1%, methylparaben 0.15%, arginine 0.6%, nicotinamide 0.5%, hexylene glycol 0.5%, pigment 0.02%, and water in balance.
The preparation process is the same as in example 1.
Comparative example 4:
a soft and skin-tendering two-phase sleep mask comprises the following formula:
the internal phase comprises the following components in percentage by weight: 3% of C14-22 alcohol/C12-20 alkyl glucoside, 2% of cetylstearyl alcohol, 0.02% of astaxanthin, 9% of cyclopenta dimethyl siloxane/cyclohexasiloxane, 4% of dimethyl siloxane, 3% of glycerol, 5% of methyl propylene glycol, 0.15% of methyl hydroxybenzoate, 0.2% of xanthan gum, 0.8% of acryloyl dimethyl taurate/VP copolymer, 0.6% of phenoxyethanol/ethylhexyl glycerol, 0.1% of essence and the balance of water;
the external phase comprises the following components in percentage by weight: carbomer 0.6%, glycerin 5%, methyl propylene glycol 5%, xanthan gum 0.2%, sodium hyaluronate 0.1%, methylparaben 0.15%, arginine 0.6%, nicotinamide 0.5%, hexylene glycol 0.5%, pigment 0.02%, and water in balance.
The preparation process is the same as in example 1.
The stability test method comprises the following steps: the two-phase sleeping masks prepared in examples 1 to 5 and comparative examples 1 to 4 were prepared into finished products according to the process described in example 1, and were placed in three environments of 45 ℃, 48 ℃, 5 ℃ and-15 ℃ for one month, respectively, and then the stability results were observed, as shown in table 1.
Table 1 table of stability test results
From the above results, it can be seen that the two-phase cosmetics described in examples 1 to 5/comparative examples 1 to 4 all had acceptable stability.
Non-traumatic human body efficacy evaluation
Trial test results were performed on the two-phase cosmetics prepared in examples 1 to 5 and comparative examples 1 to 4. Meanwhile, a commercially available sleep mask which is declared to have good moisturizing, softening and skin tendering effects is used as a control group. Test objects: each experimental group was 25 women, aged 22-35 years; test area: face and canthus crow feet regions. The use method comprises the following steps: 2 times daily for 4 weeks; and (3) testing items: skin moisture, skin softness, skin smoothness, wrinkle depth. See table 2 for trial results.
TABLE 2 evaluation results of non-invasive human body efficacy
As can be seen from table 2, the two-phase sleep mask prepared in examples 1 to 5 showed good moisturizing, skin softening, skin rejuvenation, wrinkle removal, and anti-aging effects compared to the control commercial products; example 5 compared to examples 1-4, and comparative examples 1-4, shows that the combination of the compound effects of 0.5% of tetrahydro-methyl pyrimidine carboxylic acid, 0.5% of the extract of leaves/stems of Artocarpus heterophyllus, 0.05% of astaxanthin, and 0.5% of nicotinamide is the optimal combination, has the best synergistic effect, and shows good moisturizing, softening, skin-tendering and anti-aging effects on the skin.
The above detailed description of the preferred embodiment of the present invention is the result of many experiments with great expenditure of labor, money and time.
It should be understood that the above embodiments are only used for illustrating the technical solutions of the present invention, and not for limiting the same, and those skilled in the art can modify the technical solutions described in the above embodiments, or make equivalent substitutions for some technical features; and all such modifications and alterations are intended to fall within the scope of the appended claims.
Claims (15)
1. A soft and skin-tendering two-phase sleeping mask is characterized by consisting of an inner phase at the central position and an outer phase at the periphery, and the two-phase sleeping mask is composed of an inner phase and an outer phase which are measured by mass percentage,
the internal phase comprises the components:
emulsifier: 2 to 4 percent;
oily component: 5 to 12 percent;
fatty alcohol: 0.5-2%;
first suspension thickener: 0.5-1%;
first skin softening agent: 0.5-5%, the first emollient of the inner phase comprises one or more of a tetrahydro-methyl pyrimidine carboxylic acid, astaxanthin, extract of leaves/stems of Artocarpus heterophyllus;
first polyol: 5 to 10 percent;
a soothing agent: 0.05 to 0.2 percent;
a first preservative: 0.1 to 1 percent;
water, the balance;
the external phase comprises the following components:
second suspension thickener: 0.3 to 1.8 percent;
a second skin softening agent: 0.5-4%, wherein the skin softening agent of the external phase comprises one or more of niacinamide, extract of leaves/stems of Artocarpus heterophyllus, and choline salt of glycerophosphoinositide;
a second polyol: 3 to 10 percent;
a second preservative: 0.1 to 1 percent;
arginine: 0.2 to 0.8 percent;
water: and (4) the balance.
2. The biphasic sleep mask of claim 1, wherein said first emollient comprises 0.5% of tetrahydro-methyl pyrimidine carboxylic acid, 0.05% of astaxanthin, and 0.5% of leaf/stem extract of Melia officinalis.
3. The biphasic sleep mask of claim 1, wherein the first suspension thickener of the internal phase comprises xanthan gum, ammonium acryloyldimethyl taurate/VP copolymer.
4. The biphasic sleep mask of claim 2, wherein the second suspending thickener of the outer phase comprises carbomer, xanthan gum, sodium hyaluronate, from 0.1 to 0.8% by mass; xanthan gum is 0.1-0.5%; the content of sodium hyaluronate is 0.1-0.5%.
5. The biphasic sleep mask of claim 2, wherein the emulsifier of the inner phase is C14-22 alcohol/C12-20 alkyl glucoside, glyceryl stearate, PEG-100 stearate.
6. The biphasic sleep mask of claim 5, wherein the fatty alcohol is cetearyl alcohol.
7. The two-phase sleep mask as claimed in claim 1, wherein the first and second polyols are both one or both of glycerin and methyl propylene glycol.
8. The biphasic sleep mask according to claim 7, wherein the first and second polyols are a combination of glycerol and methyl propylene glycol, the mass ratio of glycerol to methyl propylene glycol of the first polyol in the inner phase being 2: 3; the second polyol in the outer phase had a ratio of glycerol to methyl propylene glycol of 3:5 by mass.
9. The bi-phasic sleep mask according to claim 1, wherein the oily component of the internal phase is one or both of cyclopentasiloxane/cyclohexasiloxane, dimethicone.
10. The biphasic sleep mask according to claim 9, wherein the oily component is a cyclopentasiloxane/cyclohexasiloxane, dimethicone composition, the mass ratio of cyclopentasiloxane/cyclohexasiloxane to dimethicone being 6: 2.
11. The biphasic sleep mask of claim 1, wherein the internal phase soothing agent is: butanediol/1, 2-pentanediol/hydroxyphenylpropionamide benzoic acid/water compositions.
12. The two-phase sleep mask as claimed in claim 1, wherein the internal phase further comprises a first pigment and essence, and the first pigment is 0.1-0.5% by mass; the essence is 0.05-0.2%.
13. The biphasic sleep mask of claim 1, wherein the external phase further comprises a second pigment, wherein the second pigment is 0.1-0.5% by mass.
14. A method of preparing a bi-phase sleep mask as claimed in claims 1 to 13, comprising:
step 1: preparation of an internal phase composition, wherein the preparation of the internal phase composition comprises the steps of:
weighing the components according to the mass percentage, putting C14-22 alcohol/C12-20 alkyl glucoside, glyceryl stearate, PEG-100 stearate, cetearyl alcohol, cyclopenta dimethyl silicone polymer/cyclohexasiloxane and polydimethylsiloxane as phase A raw materials in an oil phase pot, heating to 80-85 ℃, and uniformly mixing to form phase A;
putting glycerol, methyl propylene glycol, methyl hydroxybenzoate, xanthan gum, acryloyl dimethyl ammonium taurate/VP copolymer and water as raw materials of phase B in a water phase pot, heating to 80-85 deg.C, and mixing to form phase B;
adding the phase B into an emulsifying pot, adding the phase A into the emulsifying pot containing the phase B, controlling the stirring speed in the emulsifying pot to be 30-45rpm, starting homogenizing for 5-7 minutes, controlling the homogenizing speed to be 2000-3000rpm, preserving heat for 25-30 minutes, and vacuumizing for defoaming;
cooling the emulsifying pot, adding a first preservative, a first pigment, essence, a first skin softening agent and a soothing agent when the emulsifying pot is cooled to 35-40 ℃, uniformly stirring, and then vacuumizing again for defoaming to obtain an inner phase composition;
step 2: preparation of an external phase composition, wherein the preparation of the external phase composition comprises the steps of:
weighing the components according to the mass percentage, putting water, carbomer, glycerol, methyl propylene glycol, sodium hyaluronate, xanthan gum and methyl hydroxybenzoate into an emulsifying pot, heating to 80-85 ℃, uniformly mixing to form a phase C, carrying out vacuum defoaming on the phase C, and then cooling;
preheating arginine and water in a ratio of 1:5 to dissolve into an arginine aqueous solution, stirring and cooling the arginine aqueous solution to 60-65 ℃ in an emulsifying pot, adding the arginine aqueous solution into the phase C, and uniformly mixing;
and cooling the emulsifying pot, adding a second preservative, a second pigment and a second skin softening agent when the emulsifying pot is cooled to 35-40 ℃, uniformly stirring, and then vacuumizing and defoaming again to obtain the external-phase composition.
15. A method of preparing a two phase sleep mask as claimed in claim 14, comprising the steps of:
step A, filling an external phase composition, namely adding the prepared external phase composition into a filling machine with a heating device, stirring and heating to 55-60 ℃, adjusting the filling machine to fill 55% of the external phase composition into a packaging material to obtain a semi-finished product;
and step B, filling the internal phase composition, adding the prepared internal phase composition into a filling machine, adjusting the filling opening of the filling machine to enable the filling opening to be opposite to the center of the semi-finished product prepared in the step A, and filling the internal phase composition with the volume of 45% of the packaging material into the semi-finished product to obtain the finished product of the two-phase sleep mask.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010526486.8A CN111514052A (en) | 2020-06-09 | 2020-06-09 | Soft and skin-tendering two-phase sleep mask and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010526486.8A CN111514052A (en) | 2020-06-09 | 2020-06-09 | Soft and skin-tendering two-phase sleep mask and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111514052A true CN111514052A (en) | 2020-08-11 |
Family
ID=71911791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010526486.8A Pending CN111514052A (en) | 2020-06-09 | 2020-06-09 | Soft and skin-tendering two-phase sleep mask and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111514052A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112656717A (en) * | 2020-12-31 | 2021-04-16 | 彭氏(惠州)实业发展有限公司 | Double-layer mask and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103735470A (en) * | 2014-01-23 | 2014-04-23 | 广州丹奇日用化工厂有限公司 | Two-phase cosmetic containing apple stem cell extract and preparation method thereof |
| CN106963670A (en) * | 2017-04-19 | 2017-07-21 | 北京赛尔佳人化妆品有限公司 | A kind of marine alga moisture saver mask liquid and preparation method thereof |
| CN107582478A (en) * | 2017-09-07 | 2018-01-16 | 蝶柔化妆品(浙江)有限公司 | A kind of salubrious emollient cream |
| CN108969433A (en) * | 2018-07-12 | 2018-12-11 | 广州皓雨投资有限公司 | Double-colored facial treatment mask and preparation method thereof with whitening, moisturizing and Shu Min effect |
| CN110840764A (en) * | 2019-11-29 | 2020-02-28 | 广州澳希亚实业有限公司 | Cosmetic composition with long-acting relieving and repairing effects and application thereof |
-
2020
- 2020-06-09 CN CN202010526486.8A patent/CN111514052A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103735470A (en) * | 2014-01-23 | 2014-04-23 | 广州丹奇日用化工厂有限公司 | Two-phase cosmetic containing apple stem cell extract and preparation method thereof |
| CN106963670A (en) * | 2017-04-19 | 2017-07-21 | 北京赛尔佳人化妆品有限公司 | A kind of marine alga moisture saver mask liquid and preparation method thereof |
| CN107582478A (en) * | 2017-09-07 | 2018-01-16 | 蝶柔化妆品(浙江)有限公司 | A kind of salubrious emollient cream |
| CN108969433A (en) * | 2018-07-12 | 2018-12-11 | 广州皓雨投资有限公司 | Double-colored facial treatment mask and preparation method thereof with whitening, moisturizing and Shu Min effect |
| CN110840764A (en) * | 2019-11-29 | 2020-02-28 | 广州澳希亚实业有限公司 | Cosmetic composition with long-acting relieving and repairing effects and application thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112656717A (en) * | 2020-12-31 | 2021-04-16 | 彭氏(惠州)实业发展有限公司 | Double-layer mask and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI324522B (en) | External dermal preparation | |
| EP0944310A4 (en) | Stabilized ascorbyl compositions | |
| CN107095807B (en) | Double-layer bath foam and preparation method thereof | |
| CN111096912A (en) | Bicontinuous phase type eye and lip makeup remover and preparation method thereof | |
| CN115006285A (en) | Smoothie-like makeup remover composition and preparation method thereof | |
| CN103816084A (en) | Slow- release lotion carrier for whitening and spot removing, and preparation method thereof | |
| CN104997653A (en) | Moisturizer suitable for being used on oily skin and preparation method thereof | |
| KR20200060837A (en) | Hydrogel cosmetic compositions for anti-wrinkle including as effective ingredient mixed extracts of natural products | |
| KR20140048700A (en) | Natural soap by using of ripen and decocted oriental medicine with the function of making age spots and wrinkles better and manufacturing method thereof | |
| CN111514052A (en) | Soft and skin-tendering two-phase sleep mask and preparation method thereof | |
| KR102309300B1 (en) | Functional cosmetic composition for skin wrinkle improvement | |
| CN109700675A (en) | A kind of cell brings back to life careless frost and preparation method thereof | |
| CN109363977A (en) | Clear CC frost of a kind of moist water profit and preparation method thereof | |
| CN109528518A (en) | A kind of face cream and preparation method thereof | |
| CN109330927A (en) | One kind, which is moistened, repairs plain face frost and preparation method thereof | |
| CN106551849A (en) | A kind of Lignum Aquilariae Resinatum facial film and preparation technology | |
| CN106398926A (en) | Essential oil handmade soap with effects of cooling, moisturizing and cleaning skin | |
| CN110559200A (en) | lip glaze | |
| CN109481325A (en) | It is a kind of to repair face beauty cream and preparation method thereof containing the continuous double thin powder of flower Chinese bush cherry | |
| MX2010010074A (en) | Composition comprising pure aloe and its use as a cosmetic base. | |
| CN108096177A (en) | A kind of compound stem cell factor cosmetic composition and its application | |
| CN104922007A (en) | Wrinkle-removal essence | |
| KR101677546B1 (en) | Composition of sleeping type pack comprising MSM and snail secretion filtrate and manufacturing method thereof | |
| TW202239399A (en) | Natural waterproof eye pencil cosmetic composition and method for manufacturing natural waterproof eye pencil cosmetic through the same | |
| CN106726981A (en) | A kind of soft and moist nourishing lip-stick and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200811 |